Results 241 to 250 of about 489,349 (309)

Identification and structure-activity relationship analysis of minimal fusion inhibitors targeting measles virus F protein. [PDF]

RSC Med Chem
Kobayashi K, Yamaguchi Y, Itahara M, Hirata K, Aoki K, Iwamoto N, Hayashi H, Kodama E, Oishi S.   +8 more
europepmc   +1 more source

Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks.

JAMA Intern Med
Silva JBB, Hsieh HT, Howe CJ, Gravenstein S, Reich LA, Zullo AR.   +5 more
europepmc   +1 more source

Erratum for the Research Article "Control of antiviral innate immune response by protein geranylgeranylation" by S. Yang <i>et al</i>.

Sci Adv
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antiviral drugs

Pharmaceutisch Weekblad, 1991
There are only a limited number of effective, non-toxic antiviral drugs for clinical use, whereas there is a great need for such drugs. Especially for the treatment of patients infected with the human immuno-deficiency virus (HIV) anti-HIV drugs are required. At the same time viral infections secondary to AIDS cannot yet be treated effectively.
E H, Wiltink, R, Janknegt
openaire   +2 more sources

New Antivirals and Antiviral Resistance

2004
The field of antiviral therapy is relatively new. Whereas the first antibiotics were available in the 1940s, the first antiviral agent (idoxuridine) was not licensed until the 1960s. Furthermore, the number of antiviral agents available to clinicians today pale in comparison to the number of antibacterial agents.
openaire   +2 more sources

Antivirals

Nature Biotechnology, 2022
openaire   +2 more sources